Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126752033 | 12675203 | 3 | F | 2016 | 20160909 | 20160822 | 20160915 | EXP | US-BAUSCH-BL-2016-019899 | BAUSCH AND LOMB | 0.00 | F | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126752033 | 12675203 | 1 | PS | XIFAXAN | RIFAXIMIN | 1 | Oral | SMPP | 21361 | 550 | MG | TABLET | BID | ||||||
| 126752033 | 12675203 | 2 | SS | XIFAXAN | RIFAXIMIN | 1 | SMPP | 21361 | |||||||||||
| 126752033 | 12675203 | 3 | SS | LACTULOSE. | LACTULOSE | 1 | Unknown | AS NEEDED | U | SMPP | 0 | ||||||||
| 126752033 | 12675203 | 4 | SS | LACTULOSE. | LACTULOSE | 1 | U | SMPP | 0 | ||||||||||
| 126752033 | 12675203 | 5 | C | LATANOPROST. | LATANOPROST | 1 | 0 | ||||||||||||
| 126752033 | 12675203 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 126752033 | 12675203 | 7 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 0 | ||||||||||||
| 126752033 | 12675203 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | TABLET | QD | ||||||||||
| 126752033 | 12675203 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126752033 | 12675203 | 10 | C | GENERLAC | LACTULOSE | 1 | 0 | SOLUTION | |||||||||||
| 126752033 | 12675203 | 11 | C | NEOMYCIN | NEOMYCIN | 1 | 0 | ||||||||||||
| 126752033 | 12675203 | 12 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126752033 | 12675203 | 1 | Antibiotic therapy |
| 126752033 | 12675203 | 2 | Bowel movement irregularity |
| 126752033 | 12675203 | 3 | Liver disorder |
| 126752033 | 12675203 | 4 | Detoxification |
| 126752033 | 12675203 | 5 | Eye disorder |
| 126752033 | 12675203 | 6 | Product used for unknown indication |
| 126752033 | 12675203 | 7 | Product used for unknown indication |
| 126752033 | 12675203 | 8 | Product used for unknown indication |
| 126752033 | 12675203 | 9 | Product used for unknown indication |
| 126752033 | 12675203 | 10 | Product used for unknown indication |
| 126752033 | 12675203 | 11 | Product used for unknown indication |
| 126752033 | 12675203 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126752033 | 12675203 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126752033 | 12675203 | Blood sodium decreased | |
| 126752033 | 12675203 | Drug dose omission | |
| 126752033 | 12675203 | Fall | |
| 126752033 | 12675203 | Feeling abnormal | |
| 126752033 | 12675203 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126752033 | 12675203 | 1 | 20160616 | 0 | ||
| 126752033 | 12675203 | 3 | 2016 | 0 |